Hikma Pharmaceuticals PLC Financial Flexibility Index
Hikma Pharmaceuticals PLC financial flexibility index. Hikma Pharmaceuticals PLC (HIK) has a Financial Flexibility Index of 0.08x as of June 2025. Free cash flow of GBX229.00 Million (operating CF GBX161.00 Million minus capex GBX68.00 Million) represents 0% of total liabilities (GBX3.00 Billion). Explore HIK capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Hikma Pharmaceuticals PLC (2002–2024)
Financial flexibility index of Hikma Pharmaceuticals PLC from 2002 to 2024. Historical Financial Flexibility Index trend for Hikma Pharmaceuticals PLC across 23 annual periods. Check Hikma Pharmaceuticals PLC total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Hikma Pharmaceuticals PLC Financial Flexibility Index by Year (2002–2024)
Hikma Pharmaceuticals PLC financial flexibility index by year from 2002 to 2024. Year-by-year free cash flow to debt coverage for Hikma Pharmaceuticals PLC. For the full cash flow conversion analysis, see Hikma Pharmaceuticals PLC cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (GBX) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.26x | GBX729.00 Million | GBX564.00 Million | GBX2.81 Billion | ▼ -17.6% |
| 2023 | 0.31x | GBX777.00 Million | GBX608.00 Million | GBX2.47 Billion | ▼ -3.3% |
| 2022 | 0.33x | GBX755.00 Million | GBX530.00 Million | GBX2.32 Billion | ▼ -28.6% |
| 2021 | 0.46x | GBX867.00 Million | GBX638.00 Million | GBX1.91 Billion | ▲ +31.4% |
| 2020 | 0.35x | GBX688.00 Million | GBX464.00 Million | GBX1.99 Billion | ▼ -5.2% |
| 2019 | 0.37x | GBX658.00 Million | GBX472.00 Million | GBX1.80 Billion | ▲ +22.5% |
| 2018 | 0.30x | GBX537.00 Million | GBX430.00 Million | GBX1.80 Billion | ▲ +0.9% |
| 2017 | 0.30x | GBX550.00 Million | GBX443.00 Million | GBX1.86 Billion | ▲ +39.1% |
| 2016 | 0.21x | GBX415.00 Million | GBX293.00 Million | GBX1.95 Billion | ▼ -40.9% |
| 2015 | 0.36x | GBX448.00 Million | GBX366.00 Million | GBX1.25 Billion | ▼ -27.8% |
| 2014 | 0.50x | GBX516.00 Million | GBX425.00 Million | GBX1.03 Billion | ▲ +12.7% |
| 2013 | 0.44x | GBX396.00 Million | GBX337.00 Million | GBX895.00 Million | ▲ +43.3% |
| 2012 | 0.31x | GBX272.35 Million | GBX182.16 Million | GBX882.26 Million | ▲ +32.8% |
| 2011 | 0.23x | GBX180.64 Million | GBX102.64 Million | GBX777.01 Million | ▼ -55.7% |
| 2010 | 0.53x | GBX191.98 Million | GBX138.79 Million | GBX365.52 Million | ▲ +22.2% |
| 2009 | 0.43x | GBX145.90 Million | GBX105.52 Million | GBX339.46 Million | ▲ +24.5% |
| 2008 | 0.35x | GBX123.39 Million | GBX57.87 Million | GBX357.46 Million | ▲ +65.2% |
| 2007 | 0.21x | GBX98.11 Million | GBX43.12 Million | GBX469.38 Million | ▼ -64.9% |
| 2006 | 0.59x | GBX82.43 Million | GBX29.99 Million | GBX138.56 Million | ▲ +15.9% |
| 2005 | 0.51x | GBX56.70 Million | GBX32.71 Million | GBX110.48 Million | ▼ -4.0% |
| 2004 | 0.53x | GBX54.17 Million | GBX32.84 Million | GBX101.31 Million | ▲ +67.3% |
| 2003 | 0.32x | GBX18.35 Million | GBX18.35 Million | GBX57.39 Million | ▲ +4.3% |
| 2002 | 0.31x | GBX14.35 Million | GBX14.35 Million | GBX46.84 Million | — |